Who to Test for Hepatitis C Virus in the Middle East and North Africa?: Pooled Analyses of 2,500 Prevalence Measures, Including 49 Million Tests

Expanding hepatitis C virus (HCV) treatment coverage is challenged by limited testing and diagnosis. This study assessed the risk of exposure, for the Middle East and North Africa, by population, yields of testing, and program efficiency of testing strategies. A standardized and systematically assem...

Descripción completa

Detalles Bibliográficos
Autores principales: Chemaitelly, Hiam, Mahmud, Sarwat, Kouyoumjian, Silva P., Al‐Kanaani, Zaina, Hermez, Joumana G., Abu‐Raddad, Laith J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396361/
https://www.ncbi.nlm.nih.gov/pubmed/30859146
http://dx.doi.org/10.1002/hep4.1310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396361/
https://www.ncbi.nlm.nih.gov/pubmed/30859146
http://dx.doi.org/10.1002/hep4.1310

Ejemplares similares